Cancer Communications
indexed by SCI

About the cover
About the cover

Dec. 2016; Volume 35 Issue 12

1, On December 19, 1978, cisplatin, the "penicillin of cancer drugs", was approved for use in testicular and ovarian cancers by the U.S. Food and Drug Administration.

2, In December 1942, nitrogen mustards started to be used as an effective treatment for cancer for the treatment of lymphoma in human clinical trials, which is the beginning of the modern era of cancer chemotherapy.

Research Highlight
Implications of vessel co-option in sorafenib-resistant hepatocellular carcinoma
Elizabeth A. Kuczynski and Robert S. Kerbel
[ Abstract  598]  [ PDF Full-text  663]   [ HTML Full-text  257]    Epub: 2016-12-26  doi: 10.1186/s40880-016-0162-7
Gemcitabine improves survival in patients with recurrent or metastatic nasopharyngeal carcinoma
Shaodong Hong and Li Zhang
[ Abstract  497]  [ PDF Full-text  603]   [ HTML Full-text  399]    Epub: 2016-12-23  doi: 10.1186/s40880-016-0163-6
Combination therapy in cancer: effects of angiogenesis inhibitors on drug pharmacokinetics and pharmacodynamics
Ilaria Fuso Nerini, Marta Cesca, Francesca Bizzaro and Raffaella Giavazzi
[ Abstract  668]  [ PDF Full-text  740]   [ HTML Full-text  732]    Epub: 2016-6-29  doi: 10.1186/s40880-016-0123-1
Defeating cancer: the 150 most important questions in cancer research and clinical oncology
Chao-Nan Qian, Wei Zhang and Rui-Hua Xu
[ Abstract  448]  [ PDF Full-text  604]   [ HTML Full-text  428]    Epub: 2016-12-30  doi: 10.1186/s40880-016-0165-4
Original Article
Development and validation of a nomogram for predicting the survival of patients with non-metastatic nasopharyngeal carcinoma after curative treatment
Wenhua Liang, Guanzhu Shen, Yaxiong Zhang, Gang Chen, Xuan Wu, Yang Li, Anchuan Li, Shiyang Kang, Xi Yuan, Xue Hou, Peiyu Huang, Yan Huang, Hongyun Zhao, Ying Tian, Chong Zhao and Li Zhang
[ Abstract  677]  [ PDF Full-text  701]   [ HTML Full-text  258]    Epub: 2016-12-26  doi: 10.1186/s40880-016-0160-9
MicroRNA-506 is up-regulated in the development of pancreatic ductal adenocarcinoma and is associated with attenuated disease progression
Run-Fen Cheng, Jian Wang, Jing-Yi Zhang, Lin Sun, Yan-Rui Zhao, Zhi-Qiang Qiu, Bao-Cun Sun and Yan Sun
[ Abstract  965]  [ PDF Full-text  1264]   [ HTML Full-text  986]    Epub: 2016-7-2  doi: 10.1186/s40880-016-0128-9
Prognostic factors and failure patterns in non-metastatic nasopharyngeal carcinoma after intensity-modulated radiotherapy
Yan-Ping Mao, Ling-Long Tang, Lei Chen, Ying Sun, Zhen-Yu Qi, Guan-Qun Zhou, Li-Zhi Liu, Li Li, Ai-Hua Lin and Jun Ma
[ Abstract  424]  [ PDF Full-text  614]   [ HTML Full-text  403]    Epub: 2016-12-30  doi: 10.1186/s40880-016-0167-2
The clinical association of programmed cell death protein 4 (PDCD4) with solid tumors and its prognostic significance: a meta-analysis
John Zeng Hong Li, Wei Gao, Wai-Kuen Ho, Wen Bin Lei, William Ignace Wei, Jimmy Yu-Wai Chan and Thian-Sze Wong
[ Abstract  522]  [ PDF Full-text  534]   [ HTML Full-text  454]    Epub: 2016-11-20  doi: 10.1186/s40880-016-0158-3
Phase II open-label study of recombinant circularly permuted TRAIL as a single-agent treatment for relapsed or refractory multiple myeloma
Yun Leng, Lugui Qiu, Jian Hou, Yaozhong Zhao, Xuejun Zhang, Shifang Yang, Hao Xi, Zhongxia Huang, Ling Pan and Wenming Chen
[ Abstract  580]  [ PDF Full-text  638]   [ HTML Full-text  596]    Epub: 2016-9-8  doi: 10.1186/s40880-016-0140-0
Original Article
ABO blood group is a predictor of survival in patients with laryngeal cancer
Ting Jin, Pei-Jing Li, Xiao-Zhong Chen and Wei-Han Hu
[ Abstract  544]  [ PDF Full-text  620]   [ HTML Full-text  508]    Epub: 2016-10-17  doi: 10.1186/s40880-016-0152-9
New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study
Qing-Qing Cai, Li-Yang Hu, Qi-Rong Geng, Jie Chen, Zhen-Hai Lu, Hui-Lan Rao, Qing Liu, Wen-Qi Jiang, Hui-Qiang Huang, Tong-Yu Lin and Zhong-Jun Xia
[ Abstract  573]  [ PDF Full-text  814]   [ HTML Full-text  567]    Epub: 2016-9-13  doi: 10.1186/s40880-016-0150-y
Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy
Yu-Xiang He, Ying Wang, Peng-Fei Cao, Lin Shen, Ya-Jie Zhao, Zi-Jian Zhang, Deng-Ming Chen, Tu-Bao Yang, Xin-Qiong Huang, Zhou Qin, You-Yi Dai and Liang-Fang Shen
[ Abstract  611]  [ PDF Full-text  849]   [ HTML Full-text  475]    Epub: 2016-11-17  doi: 10.1186/s40880-016-0159-2
Study Protocol
Study protocol of the Asian XELIRI ProjecT (AXEPT): a multinational, randomized, non-inferiority, phase III trial of second-line chemotherapy for metastatic colorectal cancer, comparing the efficacy and safety of XELIRI with or without bevacizumab versus FOLFIRI with or without bevacizumab
Masahito Kotaka, Ruihua Xu, Kei Muro, Young Suk Park, Satoshi Morita, Satoru Iwasa, Hiroyuki Uetake, Tomohiro Nishina, Hiroaki Nozawa, Hiroshi Matsumoto, Kentaro Yamazaki, Sae-Won Han, Wei Wang, Joong Bae Ahn, Yanhong Deng, Sang-Hee Cho, Yi Ba, Keun-Wook Lee, Tao Zhang, Taroh Satoh, Marc E. Buyse, Baek-Yeol Ryoo, Lin Shen, Junichi Sakamoto and Tae Won Kim
[ Abstract  516]  [ PDF Full-text  676]   [ HTML Full-text  399]    Epub: 2016-12-26  doi: 10.1186/s40880-016-0166-3
Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma
Lin Kong, Jing Gao, Jiyi Hu, Weixu Hu, Xiyin Guan, Rong Lu and Jiade J. Lu
[ Abstract  540]  [ PDF Full-text  494]   [ HTML Full-text  402]    Epub: 2016-12-26  doi: 10.1186/s40880-016-0164-5

CJC Wechat 微信公众号



Editorial Manager

CC adopts Editorial Manager to manage its submissions from Dec.18, 2014


Reference style for  

 Reference Manager

Editorial Manager





Advanced search


CJC is now published by BioMed Central

© Chinese Journal of Cancer

Sun Yat-sen University Cancer Center

651 Dongfeng Road East, Guangzhou 510060, P. R. China